​

Integra LifeSciences (IART) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IART Stock Forecast

Integra LifeSciences (IART) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a -23.43% decline from the last price of $26.12.

$15 $21 $27 $33 $39 $45 High: $20 Avg: $20 Low: $20 Last Closed Price: $26.12

IART Stock Rating

Integra LifeSciences stock's rating consensus is Sell, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (33.33%), 1 Hold (16.67%), 3 Sell (50.00%), and 0 Strong Sell (0.00%).

Sell
Total 6 0 3 1 2 Strong Sell Sell Hold Buy Strong Buy

IART Forecast vs Benchmarks

TypeNameUpside
StockIntegra LifeSciences-23.43%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts--8
Avg Price Target--$26.63
Last Closing Price$26.12$26.12$26.12
Upside/Downside--1.95%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 251162212
Dec, 242162213
Nov, 245462219
Oct, 245463220
Sep, 245463220
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 07, 2024Ryan ZimmermanBTIG$20.00$17.4314.74%-23.43%
Jul 30, 2024Richard NewitterTruist Financial$26.00$24.595.73%-0.46%
Jul 30, 2024Joanne WuenschCitigroup$23.00$25.42-9.52%-11.94%
Jul 29, 2024Ryan ZimmermanBTIG$22.00$25.42-13.45%-15.77%
Jul 16, 2024Richard NewitterTruist Financial$32.00$29.847.24%22.51%
May 07, 2024Richard NewitterTruist Financial$25.00$23.148.04%-4.29%
May 07, 2024David TurkalyJMP Securities$40.00$23.1472.86%53.14%
May 06, 2024Vik ChopraWells Fargo$25.00$23.148.04%-4.29%
Oct 26, 2022Matt O'BrienPiper Sandler$50.00$46.856.72%91.42%
Jul 28, 2022FY22 EPSPiper Sandler$55.00$56.53-2.71%110.57%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 04, 2024CitigroupSellSellhold
Jul 30, 2024JMP SecuritiesMarket OutperformMarket Outperformhold
Jul 30, 2024CitigroupNeutralSelldowngrade
Jul 29, 2024BTIGSellNegativedowngrade
Jul 29, 2024BTIGSelldowngrade
Jul 15, 2024Morgan StanleyUnderweightUnderweighthold
Jul 10, 2024CitigroupNeutralNeutralhold
May 22, 2024CitigroupNeutralNeutralhold
May 07, 2024Wells FargoMarket OutperformMarket Outperformhold
May 07, 2024JMP SecuritiesOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.59$2.00$2.18$0.85----
Avg Forecast$2.35$3.18$3.31$3.11$2.45$2.51$2.78$3.38
High Forecast$2.33$3.14$3.29$3.08$2.43$2.43$1.75$3.35
Low Forecast$2.38$3.21$3.33$3.12$2.47$2.60$3.64$3.40
Surprise %-32.34%-37.11%-34.14%-72.67%----

Revenue Forecast

$1B $1B $2B $2B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.37B$1.54B$1.56B$1.54B----
Avg Forecast$1.37B$1.54B$1.56B$1.54B$1.61B$1.71B$1.79B$1.94B
High Forecast$1.36B$1.53B$1.55B$1.53B$1.60B$1.70B$1.79B$1.93B
Low Forecast$1.38B$1.55B$1.56B$1.55B$1.62B$1.72B$1.79B$1.95B
Surprise %-0.03%0.14%-0.03%-0.16%----

Net Income Forecast

$50M $100M $150M $200M $250M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$133.89M$169.07M$180.55M$67.74M----
Avg Forecast$108.10M$144.29M$161.85M$67.74M$196.95M$202.38M$216.78M$271.54M
High Forecast$86.29M$115.43M$129.48M$54.19M$195.34M$195.52M$140.76M$269.14M
Low Forecast$129.91M$173.14M$194.22M$81.29M$198.56M$209.25M$292.79M$273.45M
Surprise %23.86%17.18%11.55%-----

IART Forecast FAQ

Is Integra LifeSciences stock a buy?

Integra LifeSciences stock has a consensus rating of Sell, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Integra LifeSciences is a less favorable investment for most analysts.

What is Integra LifeSciences's price target?

Integra LifeSciences's price target, set by 6 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential -23.43% change from the previous close price of $26.12.

How does Integra LifeSciences stock forecast compare to the average forecast of its sector, industry, and investment themes?

Integra LifeSciences stock forecast shows a -23.43% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for Integra LifeSciences over the past three months?

  • January 2025: 8.33% Strong Buy, 8.33% Buy, 50.00% Hold, 16.67% Sell, 16.67% Strong Sell.
  • December 2024: 15.38% Strong Buy, 7.69% Buy, 46.15% Hold, 15.38% Sell, 15.38% Strong Sell.
  • November 2024: 26.32% Strong Buy, 21.05% Buy, 31.58% Hold, 10.53% Sell, 10.53% Strong Sell.

What is Integra LifeSciences’s EPS forecast?

Integra LifeSciences's average annual EPS forecast for its fiscal year ending in December is 2.45 for 2024, a 188.24% increase from the reported $0.85 in 2023. The prediction for 2025 is $2.51, $2.78 for 2026, and $3.38 for 2027.

What is Integra LifeSciences’s revenue forecast?

Integra LifeSciences's average annual revenue forecast for its fiscal year ending in December is $1.61B for 2024, a 4.65% increase from the reported $1.54B in 2023. The forecast for 2025 is $1.71B, $1.79B for 2026, and $1.94B for 2027.

What is Integra LifeSciences’s net income forecast?

For its fiscal year ending in December, Integra LifeSciences's average annual net income forecast is $196.95M for 2024, reflecting an 190.74% increase from the reported $67.74M in 2023. The projection for 2025 is $202.38M, $216.78M for 2026, and $271.54M for 2027.